It is also unusual for people to be involved in the cancer research, but I possess a close connection with cancer. I have seen my friend becoming a prey to cancer. In my situation, my friend died at a very young age when awareness about cancer was entirely missing. That instance stimulated me to contribute to the human development. I realized that this field can be the best contribution that I can do to save lives and perform scientific research to disclose the mysteries associated with cancer. Human microbiome is entirely new to me but I knew that it plays a role in the tumours.
Apart from cancer biology, the global concern of resistance to antimicrobials among pathogenic bacteria such as MRSA and C.diff has also drawn my attention. It affects the efficacy of antimicrobial drugs for the prevention and treatment to common infections. This is resulting in deterioration of infectious disease, increasing mortality and the costs of health care. Therefore, research on antimicrobial resistance could promote better understanding in the various genetic components of bacteria that contribute to antibiotic resistance and the development of new antibiotics. It is also beneficial to allow healthcare professional to personalise antibiotic treatment, which could extend the life span of different antibiotics and reduce the chance of treatment failure.
My motivation to the subject is further improved as I read Greatest show on Earth written by Dawkins and the book titled Cancer by Scotting. Biology is not yet another subject to be read at school. It determines the association between various elements. The research given by Scotting says that carcinogens transport throughout body with the help of lymphatic system. My experience and study about cancer have encouraged me to identify better solutions to the treatment failure. It is impossible to suggest solutions without having proper stance on the subject. This is the reason to pursue a higher degree on this subject. Antibiotics seem to be the perfect solution to many diseases. However, studying the trend of antibiotics over 20 classes are marketed during 20th century, which is a rapid development. Killing bacteria is not the solution. The antibiotic has to be safer and cheaper. Furtherly speaking, it has to be accessible by all. New compounds have been introduced to solve a number of issues while their sustainability is still a question.
In addition to cancer biology, the antimicrobial domain is so vast that new classes are introduced year by year. Instead of exposing such classes to clinical trials, they are directly exposed to the market usage. I find that the antibiotic resistance is an ever growing problem not only in developing countries but also in developed countries. The reason behind my interest is to demand for better diagnostics. When the diagnosis happens to a better extent, the public hygiene becomes better.